Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization in India to manufacture and sell its SARAPLEX Influenza Multiplex Test Kit to clinical laboratories as an in vitro diagnostic for the detection and differentiation of Influenza A and Influenza B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
